According to filings with the U.S. Securities and Exchange Commission, RPM-One is raising up to $14,752,556.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About RPM-One
As a healthcare executive, Ive become all too familiar with the challenges of our healthcare system. While the emergence of technology has promised to address health disparities, improve patient outcomes, relieve professional burden, and deliver cost savings, it has failed to deliver on its potential. Like many, I have spent most of my career on the sidelines discussing problems and theoretical solutions from a comfortable office while witnessing the prevalence of chronic diseases grow and health inequities widen in our country. When I first met RPM-One Co-Founder, Matt Willert, we discussed the limitations of wearable technology and barriers to widespread adoption. Primarily, poor data integrity (limiting trust), lack of specificity and clinical workflows (limiting utility) and high cost (limiting accessibility). Based on my experience in wearable technology as a Physiologist and data scientist, and Matts success in operations, we began assessing the feasibility of a business model that would allow us to provide a solution to those who need it most. We spent months on end evaluating each and every business decision, working closely with patients and healthcare professionals, based on improving accessibility and clinical utility, not making more money.

To learn more about RPM-One, visit https://rpm-one.com/
RPM-One Linkedin Page: linkedin.com/company/rpm-one-inc/

Contact:
Kevin Longoria, Chief Executive Officer
602-751-6179
https://www.linkedin.com/in/kevin-longoria-2b581b164/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.